Spots Global Cancer Trial Database for A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
Official Title: A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT-751 in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
Study ID: NCT00354562
Study Description
Brief Summary: To determine the efficacy of ABT-751 when administered in combination with standard docetaxel in subjects with advanced or metastatic NSCLC.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Site Ref # / Investigator 3572, Birmingham, Alabama, United States
Site Ref # / Investigator 4771, Burbank, California, United States
Site Ref # / Investigator 3574, Orange, California, United States
Site Ref # / Investigator 3567, Rancho Mirage, California, United States
Site Ref # / Investigator 3512, Gurnee, Illinois, United States
Site Ref # / Investigator 3565, Hackensack, New Jersey, United States
Site Ref # / Investigator 3569, Buffalo, New York, United States
Site Ref # / Investigator 3511, Cleveland, Ohio, United States
Site Ref # / Investigator 5237, Ravenna, Ohio, United States
Site Ref # / Investigator 3551, Crossville, Tennessee, United States
Site Ref # / Investigator 3549, Knoxville, Tennessee, United States
Site Ref # / Investigator 3571, Nashville, Tennessee, United States
Site Ref # / Investigator 3510, Weston, Wisconsin, United States
Site Ref # / Investigator 3563, Sydney, Nova Scotia, Canada
Site Ref # / Investigator 3559, Barrie, Ontario, Canada
Site Ref # / Investigator 3561, Sudbury, Ontario, Canada
Site Ref # / Investigator 3560, Greenfield Park, Quebec, Canada
Site Ref # / Investigator 3562, Montreal, Quebec, Canada
Site Ref # / Investigator 2222, Montreal, Quebec, Canada
Site Ref # / Investigator 3558, Regina, Saskatchewan, Canada
Site Ref # / Investigator 5097, Cork, , Ireland
Site Ref # / Investigator 4986, Dublin 24, , Ireland
Site Ref # / Investigator 4999, Dublin 4, , Ireland
Site Ref # / Investigator 5158, Dublin 7, , Ireland
Site Ref # / Investigator 4971, Dublin 8, , Ireland
Site Ref # / Investigator 5270, Barming, , United Kingdom
Site Ref # / Investigator 5259, Belfast, , United Kingdom
Site Ref # / Investigator 5271, Edinburgh, , United Kingdom
Site Ref # / Investigator 5017, Glasgow, , United Kingdom
Site Ref # / Investigator 5274, Hull, , United Kingdom
Site Ref # / Investigator 5273, Surrey, , United Kingdom
Site Ref # / Investigator 5268, Surrey, , United Kingdom
Contact Details
Name: Helen Eliopoulos, MD
Affiliation: Abbott
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
